Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2

The global pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to efforts in developing effective vaccine approaches. Currently, approved coronavirus disease 2019 (COVID-19) vaccines are administered through an intramuscular (I.M.) route. Here, we show that the...

Full description

Bibliographic Details

Published in:	Pathogens
Main Authors:	Wei-Chiao Huang, Kevin Chiem, Luis Martinez-Sobrido, Jonathan F. Lovell
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Subjects:	vaccines liposomes SARS-CoV-2 intranasal RBD
Online Access:	https://www.mdpi.com/2076-0817/11/9/1035